
Specialty
Education
MBCHB, University of Cape Town
University of Cape Town, Faculty of Medicine
Fellowship of the Royal College of Surgeons
South African Medical and Dental Council
Fellowship of the American College of Surgeons
Royal College of Surgeons of England
Residency, Surgery
Bronx Municipal Hospital Center
Awards
1973 -
Bronte-Stewart Prize
1973 -
Paul Martini European Prize
1966 -
Penman Memorial Bursary
Research
Tumor cultures and endocrine effects in breast cancer
New hemo-perfusion techniques for fulminant hepatic failure
Management of breast cancers
Management of colon and rectal cancers
Publications
Smith TR, Schmiedeberg P, Flax H, Wu E. Nonmucosal Predominantly Serosal Eosinophilic Enteritis: A Case Report. Clin Imaging 1990; 14: 235.
Van Hoeven KH, Hibbard CA, Flax H, Jones J, Suhrland MJ. Metastatic Malignant Neoplasms and Secondary Lymphomatous Involvement of the Breast: A Study of 43 Cases. Pathol Annu 1993; 28(II): 221.
Hummel P, Wei XJ, Gagner J, Flax H, Mittal K, Blank S. Pleomorphic Liposarcoma of the Uterus: Case Report and Literature Review. International Journal of Gynecologic Pathology 2003; 22(4): 407.
Industry Relationships
Physicians and scientists on the faculty of Mount Sinai School of Medicine often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Flax is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://www.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
9 East 63rd Street
New York, NY 10065
Fax: 212-832-9279


